跳至主要内容
临床试验/NCT00957957
NCT00957957已完成不适用

Gut Hormone Profiling in Peripheral Blood After Bariatric Surgery in Obese Patients With Type 2 Diabetes

Merck Sharp & Dohme LLC0 个研究点目标入组 22 人开始时间: 2010年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
主要终点
Change from baseline in PYY (Peptide YY) measured by ELISA 4 weeks after RYGBP

研究概览

简要总结

This study will examine changes in various gut-derived hormones in obese type 2 diabetic patients before and after elective bariatric surgery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Documented type 2 diabetes with total disease duration ≤10 years
  • BMI of at least 35 kg/m^2
  • Patient is a surgical candidate for either RYGBP, GBS or vertical sleeve gastrectomy (VSG)

排除标准

  • Any illness that might confound the results of the study or pose additional risk to the patient by participation
  • History of stroke, seizures, or other major neurological disorder
  • History of cancer
  • Patient uses or has used any medication that can alter body weight
  • Patient is unwilling or unable to follow study procedures

结局指标

主要结局

Change from baseline in PYY (Peptide YY) measured by ELISA 4 weeks after RYGBP

时间窗: Baseline and Week 4

次要结局

  • Change from baseline in PYY measured by dMS 4 weeks after RYGBP(Baseline and week 4)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验